Contact us 24/7

Diflucan

Diflucan Linked to Serious Adverse Events and Birth Defects

Diflucan is manufactured by Pfizer and was approved by the Food and Drug Association (FDA) on January 29th, 1990. Diflucan, also known as fluconazole, is used to treat yeast infections of the vagina, mouth, throat, esophagus, and other organs.

It is also used to treat meningitis caused by a certain type of fungus as well as to prevent yeast infections for patients who are likely to become infected as a result of chemotherapy or radiation therapy before a bone marrow transplant.

FDA WARNINGS OF BIRTH DEFECTS

In 2011, the FDA informed the public that chronic, high doses (400-800 mg/day) of Diflucan could be associated with a rare and distinct set of birth defects in infants when mothers are treated with the drug during the first trimester of pregnancy.

This risk, however, is not associated with single low doses (150 mg) to treat vaginal yeast infections.

In 2014, the FDA informed the public that patients being treated with Diflucan for fungal infections should monitor the development of rashes and discontinue the drug if lesions progress.

BIRTH DEFECTS NOTED BY THE FDA

  • Short, broad head
  • Abnormal looking face
  • Abnormal development of the skullcap
  • Oral cleft
  • Bowing of the thigh bones
  • Thin ribs and long bones
  • Muscle weakness
  • Joint deformities
  • Gongenital heart defects

HAVE YOU BEEN INJURED?

If you’ve been injured, we can help. Contact us